вторник, 17 мая 2011 г.

Link Between High Unexpressed Anger In MS Patients And Nervous System Damage

People with Multiple Sclerosis (MS) feel more than twice as much withheld anger as the general population and this could have an adverse effect on their relationships and health, according to a study published in the December issue of the European Journal of Neurology.



Italian researchers assessed 195 patients with MS, using a range of scales that measure anger, depression and anxiety, and then compared them with the general population.



They were surprised by the results, which showed that while patients experienced almost twice the normal level of withheld anger and exerted low levels of control on their anger, their expressed anger levels were similar to the general population.



This, together with the fact that the elevated withheld anger levels were not related to the severity of the patients' MS, suggests that these inconsistent changes were caused by nervous system damage, rather than an emotional reaction to the stress of the disease.



"We believe that the higher levels of withheld anger shown by the study subjects is due to demyelination, loss of the substance in the white matter that insulates the nerve endings and helps people receive and interpret messages from the brain" explains lead researcher Dr Ugo Nocentini from the IRCCS S Lucia Foundation in Rome.



"The way we process anger is controlled by complex interconnections between the subcortical and cortical systems, notably the amygdale and basal ganglia and the medial prefrontal cortex. We believe that the demyelination process that causes the root symptoms of MS also disrupts the pathways that control how we deal with withheld anger."



The patients who took part in the study comprised 150 with relapsing-remitting MS and 45 with progressive MS. More than two-thirds (68 per cent) were women, the average age of the participants was 40 and the average time since diagnosis was 11 years.



Researchers evaluated the participants using the State Trait Anger Expression Inventory, the Chicago Multiscale Depression Inventory and the State Trait Anxiety Inventory.



The researchers then looked at age and sex-matched subjects in the general population and identified the levels of anger experienced by the 25 per cent of people with the highest scores.



They found that MS patients:
Were more than twice as likely to experience high levels of withheld anger, with 60 per cent of patients recording the same high levels as the top 25 per cent of the general population.


Exerted a low level of control on their anger, with just 11 per cent of patients reporting the same high levels of control compared to the top 25 per cent of the general population.


Were about the same as non MS patients when it came to expressed anger, with 30 per cent of patients reporting the same high levels as the top 25 per cent of the general population.

During the study the authors also compared the anger scores against selected demographic and clinical characteristics and found they were independent of age, education, disease duration and course, disability and fatigue severity. The only notable difference was that women reported higher levels of current anxiety.



"Our findings clearly show that anger characteristics in MS patients differ from those observed in the general population and the overall results surprised the research team" concludes Dr Nocentini.



"For example, patients reported low levels of anger control and high levels of withheld anger, yet the scores for expressed anger were similar to those of the general population.



"We would have expected greater consistency between withheld and expressed anger and higher levels of expressed anger as a consequence of low anger control."



The authors conclude that damage to the fibres in the areas of the brain where anger issues are processed is the most logical explanation. They also say the findings have important implications for clinical practice.



"Anger disrupts interpersonal relationships and this is particularly true for withheld anger, which might go unrecognised by other people" says Dr Nocentini. "Witheld anger has been reported to be associated with physical problems, in particular high blood pressure and vascular disorders, and may have a negative effect on the general health of MS patients.



"Because withheld anger has no, or few, overt manifestations, and is unlikely to be recognised by clinicians or reported by patients, it is important that MS patients are asked if they experience abnormal anger."

понедельник, 16 мая 2011 г.

Could A Diagnostic Blood Test Be Created For Depression?

Psychiatry, unlike many other areas of medicine, lacks diagnostic blood tests. Blood tests have been extremely useful in helping doctors make medical diagnoses and aiding them in treatment options for conditions and diseases in most medical fields.


An article in Biological Psychiatry reports that Dutch researchers may eventually generate blood tests for psychiatric conditions, such as depression.


Under increasingly intensive research by scientists are the studies of:

Variations in DNA (genes) that can be extracted from blood cells
Genomics like proteomics, the measurement of the levels of specific proteins in the blood
Gene expression profiling, which measure the levels of RNA produced from DNA as an indication of the activity of specific genes.

Dutch researchers evaluated blood gene expression profiles in two groups of people:

Patients diagnosed with major depressive disorder (MDD)
Healthy individuals

They identified a set of 7 genes in whole blood that could tell the un-medicated MDD patients from the healthy ones.


Dr. Sabine Spijker, one of the authors, said:



This is a first, but major step in providing a molecular diagnostic tool for depression.



Experts say this type of diagnostic test would be especially useful for diagnosing mental health disorders when it is more difficult to have a conversation with the patient; it would also be unbiased.


The writers add that blood tests of this type may also help in reducing the stigma associated with mental health illness, conditions, and problems.


Dr. John Krystal, Editor of Biological Psychiatry cautions:



It is far too early to be confident that gene expression profiling will lead us to diagnostic or prognostic tests for depression. However, the objective of this line of research is extremely important. In the past, many types of tests have been explored as potential diagnostic markers, but they all have failed to have sufficient sensitivity and specificity to guide doctors in making psychiatric diagnoses or choosing between treatments. I look forward to seeing whether the patterns of gene expression profiling are replicable and diagnostically specific as multiple groups report their findings.


Hopefully, say the authors, this study may be a stepping stone towards finding markers that may predict treatment outcome and recurrence.


"Stimulated Gene Expression Profiles as a Blood Marker of Major Depressive Disorder"

Sabine Spijker, Jeroen S. Van Zanten, Simone De Jong, Brenda W.J.H. Penninx, Richard van Dyck, Frans G. Zitman, Jan H. Smit, Bauke Ylstra, August B. Smit, Witte J.G. Hoogendijk

Biological Psychiatry, Volume 68, Issue 2, 15 July 2010, Pages 179-186






In Patients With Depression It Takes Only 5 Minutes To Assess Disability

A research team has tested the utility of the short version of WHO-DAS II, a tool to assess within five minutes, disability in patients with depression, "which in the case of primary care is even more practicable than the long version of the instrument." In Spain, more than 10% of the population suffer from severe depression.



The family doctor is usually the first to screen an individual who feels depressed. For this reason, training and tools that enable the diagnosis of this illness and the disability associated with it are essential. A new study now certifies the reliability and validity of the 12-item WHO-DAS II, the short version of the World Health Organization scale to assess disability in primary care patients.



Juan Vicente Luciano's research team, at Parque Sanitario Sant Joan de D?©u, in Sant Boi de Llobregat (Barcelona), observed that the psychometric information available in Spain on WHO-DAS II in patients with depression was insufficient: "a significant limitation given the high prevalence of this pathology among patients who consult their family doctor", he explains to SINC.



The study, published in the Journal of Affective Disorders, has been based on 3,638 primary care patients from 17 Spanish provinces who have suffered "a major first depressive episode ", according to their family doctor.



"Luciano indicates that "the score obtained by patients on the new scale is more capable at predicting the severity of their depression symptoms than the scores obtained in a quality of life instrument used in the same study".



The authors conclude that the short version of this tool is "as reliable and valid as the full version" in assessing disability in patients with depression, and is even "more suitable" than the long version in the primary care field, given the short time (less than five minutes) it takes to use it.



WHO-DAS II is a tool that assesses functioning and disability in six areas (understanding and communication; ability to get by in their environment; self-care; relationships with others; daily life activities and participation in society). Its psychometric properties have been tested in more than 14 countries and in 16 different languages.



Spain: a depressed country?



Scientific literature shows a high prevalence of mental disorders in Spain. According to a study published in the journal Medicina Cl?­nica in 2006, 19.5% of the population has had a mental disorder at some stage in their life. The most frequent mental disorder is a severe depressive episode, which affects 10.5% of the population.



In 2008, further research on the frequency of depression among primary care patients in six European countries, published in the British Journal of Psychiatry, revealed that Spain has the highest rate of depression in Europe, particularly among women.



The latest data from the World Health Organization (WHO) show that depression affects 121 million people around the world and is the main cause of work-related disability. Although this pathology can be diagnosed and treated effectively in primary care, less than 25% of people affected receive the appropriate treatment.



References:
Juan V. Luciano, Jos?© L. Ayuso-Mateos, Ana Fern??ndez, Antoni Serrano-Blanco, Miquel Roca, Josep M. Haro. "Psychometric properties of the twelve item World Health Organization Disability Assessment Schedule II (WHO-DAS II) in Spanish primary care patients with a first major depressive episode". Journal of Affective Disorders 121:52-58, febrero de 2010.


King et al.: "Prevalence of common mental disorders in general practice attendees across Europe". British Journal of Psychiatry (2008);192:362-367.


Josep M. Haro, Concepci?? Palac?­n, Gemma Vilagut, Montse Mart?­nez, Mariola Bernal, Inma Luque, Miquel Codony, Montse Dolz, Jordi Alonso y el Grupo ESEMeD-Espa?±a. "Prevalencia de los trastornos mentales y factores asociados: resultados del estudio ESEMeD-Espa?±a". Medicina Cl?­nica (2006);126(12):445-51.


For Trials Documenting CVD Burden Chicago Scientist Honored

The American Heart Association awarded its Population Research Prize to Paul K. Whelton, M.D., of Loyola University in Chicago, for pioneering population trials that are the informational basis for much of today's fight against cardiovascular diseases.



"For more than two decades, Dr. Whelton has directed highly significant longitudinal, cross-sectional and interventional studies that are providing medical science vital data on the burden of disease facing populations in the United States, Southeast Asia, North Africa and South America," said Daniel Jones, M.D., president of the American Heart Association.



Jones presented the annual $5,000 award for outstanding population research during the American Heart Association's Scientific Sessions 2007 at the Orange County Convention Center.



Jones said data compiled by Whelton "have brought into sharp focus the extent of the problem that heart and blood vessel diseases pose, and have sketched a useful blueprint for preventive actions that can be taken to reduce risk and eventually conquer these diseases."



Whelton's contributions include the first worldwide estimates of the prevalence of hypertension.



Beginning in the 1980s, Whelton's research "generated compelling evidence" that high blood pressure and diabetes are risk factors for renal disease, Jones said.



Whelton has also led in identifying non-pharmacologic approaches for preventing and treating high blood pressure. He chaired the two largest lifestyle intervention trials for hypertension prevention.



After medical training in his native Ireland, Whelton served on the faculty of the Johns Hopkins School of Medicine and School of Public Health in Baltimore. He was also dean of the Tulane School of Public Health and Tropical Medicine in New Orleans before becoming president and chief executive officer of the Loyola University Health System in Chicago.






Depression Rife Among Medical Students

Medical students frequently suffer from depression, especially during their internship years. New research published in the open access journal BMC Medical Education reveals the extent of the problem and features a detailed analysis of the symptoms and sufferers.



Sergio Baldassin, from the ABC Regional Medical School, Brazil, led a team of researchers who carried out a study on 481 medical students in the private medical school near the S??o Paulo state capital. He said, "We used cluster analyses to better describe the characteristics of depressive symptoms - affective, cognitive, and somatic. This is the first study to directly evaluate, in a cross-sectional design, the characteristics of depressive symptoms by applying such clusters".



Affective symptoms represent the core symptoms of a depressive mood, based on students' reported levels of sadness, dissatisfaction, episodes of crying, irritability and social withdrawal. The cognitive cluster assessed pessimism, sense of failure or guilt, expectation of punishment, dislike of self, suicidal ideation, indecisiveness and change in body image. Finally, the somatic cluster assessed the presence of slowness, insomnia, fatigue, loss of weight and loss of sexual interest. Baldassin said, "There was a high prevalence towards depressive symptoms among medical students, particularly females, mainly involving the somatic and affective clusters. Of the students in our study, 38% had at least 10 of a possible 63 symptoms of depression".



The authors' cluster analysis found that the reasons for most students' depression scores were in the affective cluster, and that the problem was at its worst in the internship years. Cognitive cluster symptoms were also highest in this year, probably due to feelings of fear and insecurity about entry into the hospital environment. According to Baldassin, "Frequently pre-internship students fear they 'know nothing', and are insecure about the physical examination of other people". Likewise, somatic cluster scores were highest during internship, reflecting sleepless nights on call, devoid of friend and family support.



Having a parent who is a doctor was found to reduce the depression risk.



The authors conclude, "The increased depression scores during the internship period of medical school are associated with a decrease in student health, and this is probably the period when professors and educators should try to be most aware of suicidal thoughts and risk in their students".







Notes:



1. The Characteristics of Depressive Symptoms in Medical Students during Medical Education and Training: A Cross-sectional Study

Sergio Baldassin, T??nia CTF Alves, Arthur G Andrade and Luiz A Nogueira-Martins

BMC Medical Education (in press)


Article available at journal website: biomedcentral/bmcmededuc/


All articles are available free of charge, according to BioMed Central's open access policy.



2. BMC Medical Education is an open access journal publishing original peer-reviewed research articles in undergraduate, postgraduate, and continuing medical education. BMC Medical Education (ISSN 1472-6920) is indexed/tracked/covered by PubMed, MEDLINE, CAS, Scopus, EMBASE and Google Scholar.



3. BioMed Central (biomedcentral/) is an STM (Science, Technology and Medicine) publisher which has pioneered the open access publishing model. All peer-reviewed research articles published by BioMed Central are made immediately and freely accessible online, and are licensed to allow redistribution and reuse. BioMed Central is part of Springer Science+Business Media, a leading global publisher in the STM sector.

Routine Screening For Postnatal Depression Not Cost Effective, UK

Routine screening for postnatal depression in primary care - as recommended in recent guidance from the National Institute for Health and Clinical Excellence (NICE) - do not appear to represent value for money for the NHS, concludes a study published on bmj.



The results suggest that both the NICE guidance and widespread current practice should be reviewed.



More than one in 10 women suffer from postnatal depression six weeks after giving birth, yet fewer than half of cases are detected in routine clinical practice. Formal identification methods, such as postnatal or general depression questionnaires, have been advocated but have attracted substantial controversy.



Furthermore, guidelines issued by NICE in 2007 recommend the use of specific questions to identify possible postnatal depression, but the cost effectiveness of this strategy is uncertain.



So researchers at the University of York used a computer model to evaluate the cost effectiveness of formal methods to identify postnatal depression in primary care.



Routine use of either postnatal or general depression questionnaires did not appear to be cost effective compared with routine care only, largely due to the cost of managing those wrongly diagnosed as depressed, say the authors.



For example, the Edinburgh postnatal depression scale had an incremental cost effectiveness ratio of ??41,103 per quality adjusted life year or QALY (a combined measure of quantity and quality of life) compared with routine care only.



The ratio for all other strategies ranged from ??49,928 to ??272,463 per QALY compared with routine care only, well above the conventional NHS cost effectiveness threshold of ??20-30,000 per QALY.



In contrast, the strategy of administering only routine care was most likely to be cost effective.



These findings suggest that both the recent NICE guidance and widespread current practice do not result in value for money for the NHS, and do not satisfy the National Screening Committee's criteria for the adoption of a screening strategy as part of national health policy, conclude the authors



They call for further research to quantify the cost of incorrect diagnosis and the wider impact of postnatal depression treatment strategies on the quality of life of the mother and her family.



Link to paper

Source
British Medical Journal

States With Higher Uninsured Rates Have Higher Suicide Rates, According To Report

States with higher rates of residents who lack health insurance have higher rates of depression and suicide, according to an unpublished study commissioned by Mental Health America and released to USA Today. For the study, sponsored by Wyeth Pharmaceuticals, Tami Mark of Thomson Healthcare used federal data on mental health and state databases to develop a "depression index" and ranked states based on rates and seriousness of depression, and rates of suicide.

Maryland, New Jersey, Illinois and Hawaii had the lowest rates of depression and suicide, and Utah, West Virginia, Idaho and Nevada had the highest rates, the study found. According to the study, rates of suicide in states with the highest rates exceeded those in states with the lowest rates by two to four times. States with lower rates of suicide had higher rates of adults who received mental health care, more availability of psychologists and psychiatrists, and mental health parity laws that require health insurers to provide equal levels of coverage for physical and mental illnesses, the study found.

Mark said that, although the study does not link a lack of access to mental health care to higher rates of depression and suicide, "it suggests we should be monitoring mental health care and comparing outcomes." David Shearn of Mental Health America said that the study highlights the importance of health care in the 2008 presidential campaign, as well as mental health parity legislation under consideration in Congress. "There are consequences of no mental health treatment: it can cost lives," he said.

John Holahan, director of the Health Policy Center at the Urban Institute, said that the study is "pretty interesting and important because it suggests that having insurance and improving access to care has an impact on mental health and suicide" (Elias, USA Today, 11/28).

Reprinted with kind permission from kaisernetwork. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at kaisernetwork/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork, a free service of The Henry J. Kaiser Family Foundation© 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.